Evidence map›Paper›PMID 37749490›Full record

ArticleBMC infectious diseases2023

Can HIV self-testing reach first-time testers? A telephone survey among self-test end users in Côte d'Ivoire, Mali, and Senegal.

Arsène Kouassi Kra, Arlette Simo Fotso, Kouassi Noël N'guessan, Olivier Geoffroy, Sidibé Younoussa, Odé Kanku Kabemba, Papa Alioune Gueye, Pauline Dama Ndeye, Nicolas Rouveau, Marie-Claude Boily and 6 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 5 countries.

Arsène Kouassi KraCentre Population et Développement (Ceped), Institut de Recherche pour le Développement (IRD), Université Paris Cité, Inserm, Paris, France. arsene.kra.kouassi@ceped.org.ORCID http://orcid.org/0000-0003-4928-6735
Arlette Simo FotsoCentre Population et Développement (Ceped), Institut de Recherche pour le Développement (IRD), Université Paris Cité, Inserm, Paris, France.ORCID http://orcid.org/0000-0002-5006-8105
Kouassi Noël N'guessanSolidarité Thérapeutique et Initiatives pour la Santé (Solthis), Abidjan, Côte d'Ivoire.
Olivier GeoffroySolidarité Thérapeutique et Initiatives pour la Santé (Solthis), Abidjan, Côte d'Ivoire.
Sidibé YounoussaSolidarité Thérapeutique et Initiatives pour la Santé (Solthis), Bamako, Mali.
Odé Kanku KabembaSolidarité Thérapeutique et Initiatives pour la Santé (Solthis), Bamako, Mali.
Papa Alioune GueyeSolidarité Thérapeutique et Initiatives pour la Santé (Solthis), Dakar, Sénégal.
Pauline Dama NdeyeSolidarité Thérapeutique et Initiatives pour la Santé (Solthis), Dakar, Sénégal.
Nicolas RouveauCentre Population et Développement (Ceped), Institut de Recherche pour le Développement (IRD), Université Paris Cité, Inserm, Paris, France.
Marie-Claude BoilyMRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.ORCID http://orcid.org/0000-0003-3919-006X
Romain SilholMRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-5750-7609
Marc d'ElbéeDepartment of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.ORCID http://orcid.org/0000-0002-8827-019X
Mathieu Maheu-GirouxDepartment of Epidemiology and Biostatistics, School of Population and Global Health, McGill University, Montréal, QC, H3A 1A2, Canada.ORCID http://orcid.org/0000-0002-8363-4388
Anthony VautierSolidarité Thérapeutique et Initiatives pour la Santé (Solthis), Dakar, Sénégal.ORCID http://orcid.org/0000-0001-8039-6479
Joseph LarmarangeCentre Population et Développement (Ceped), Institut de Recherche pour le Développement (IRD), Université Paris Cité, Inserm, Paris, France.ORCID http://orcid.org/0000-0001-7097-700X
ATLAS team
Ministère des Solidarités et de la Santé · FRDélégation Paris 5 · FRImperial College London · GBInstitut national d'études démographiques · FRMcGill University · CAUniversity of London · GB

Funding

Medical Research Council MR/R015600/1Medical Research Council MR/X020258/1
6 · The paper itself

Abstract

backgroundCoverage of HIV testing remains sub-optimal in West Africa. Between 2019 and 2022, the ATLAS program distributed ~400 000 oral HIV self-tests (HIVST) in Côte d'Ivoire, Mali, and Senegal, prioritising female sex workers (FSW) and men having sex with men (MSM), and relying on secondary redistribution of HIVST to partners, peers and clients to reach individuals not tested through conventional testing. This study assesses the proportion of first-time testers among HIVST users and the associated factors.

methodsA phone-based survey was implemented among HIVST users recruited using dedicated leaflets inviting them to anonymously call a free phone number. We collected socio-demographics, sexual behaviours, HIV testing history, HIVST use, and satisfaction with HIVST. We reported the proportion of first-time testers and computed associated factors using logistic regression.

resultsBetween March and June 2021, 2 615 participants were recruited for 50 940 distributed HIVST (participation rate: 5.1%). Among participants, 30% received their HIVST kit through secondary distribution (from a friend, sexual partner, family member, or colleague). The proportion who had never tested for HIV before HIVST (first-time testers) was 41%. The main factors associated with being a first-time tester were sex, age group, education level, condom use, and secondary distribution. A higher proportion was observed among those aged 24 years or less (55% vs 32% for 25-34, aOR: 0.37 [95%CI: 0.30-0.44], and 26% for 35 years or more, aOR: 0.28 [0.21-0.37]); those less educated (48% for none/primary education vs 45% for secondary education, aOR: 0.60 [0.47-0.77], and 29% for higher education, aOR: 0.33 [0.25-0.44]). A lower proportion was observed among women (37% vs 43%, aOR: 0.49 [0.40-0.60]); those reporting always using a condom over the last year (36% vs 51% for those reporting never using them, aOR: 2.02 [1.59-2.56]); and those who received their HISVST kit through primary distribution (39% vs 46% for secondary distribution, aOR: 1.32 [1.08-1.60]).

conclusionATLAS HIVST strategy, including secondary distribution, successfully reached a significant proportion of first-time testers. HIVST has the potential to reach underserved populations and contribute to the expansion of HIV testing services in West Africa.

Indexed as

HIV InfectionsSexual and Gender MinoritiesSex WorkersCote d'IvoireFemaleHIV TestingHomosexuality, MaleHumansMaleMaliSelf-TestingSenegalTelephoneCôte d’IvoireHIV self-testingKey populationsMaliPhone‐based surveySenegalWest Africa

Identifiers

PMID37749490
PMCPMC10518917
OpenAlexW4387018453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.